These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Tarnow L, Astrup AS, Parving HH. Scand J Clin Lab Invest Suppl; 2005; 240():73-9. PubMed ID: 16112962 [Abstract] [Full Text] [Related]
6. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy. Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P. Diabetes Care; 2010 Jul; 33(7):1567-72. PubMed ID: 20357380 [Abstract] [Full Text] [Related]
10. Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy. Jorsal A, Tarnow L, Flyvbjerg A, Parving HH, Rossing P, Rasmussen LM. Diabetologia; 2008 Nov; 51(11):2100-7. PubMed ID: 18719882 [Abstract] [Full Text] [Related]
11. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P. Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497 [Abstract] [Full Text] [Related]
13. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial). Schutte E, Lambers Heerspink HJ, Lutgers HL, Bakker SJ, Vart P, Wolffenbuttel BH, Umanath K, Lewis JB, de Zeeuw D, Gansevoort RT. Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260 [Abstract] [Full Text] [Related]
14. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes. Rotbain Curovic V, Theilade S, Winther SA, Tofte N, Eugen-Olsen J, Persson F, Hansen TW, Jeppesen J, Rossing P. Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954 [Abstract] [Full Text] [Related]
17. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P. Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153 [Abstract] [Full Text] [Related]
19. Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study. Nin JW, Ferreira I, Schalkwijk CG, Jorsal A, Prins MH, Parving HH, Tarnow L, Rossing P, Stehouwer CD. Diabetologia; 2012 Sep; 55(9):2489-93. PubMed ID: 22752054 [Abstract] [Full Text] [Related]